Table 3 Characteristics of the AKI patients at baseline
From: A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
AKI (n = 94) | |||
|---|---|---|---|
male n (%) | 52 (55.3) | ||
Age | 47.00 ± 16.90 | ||
Body Mass Index | 23.20 (20.00, 25.20) | ||
Systolic blood pressure | 140.61 ± 21.87 | ||
Diastolic blood pressure | 83.27 ± 14.10 | ||
Diabetes n (%) | 10(10.6) | ||
C-reactive protein (mg/L) | 21.60 (7.80, 94.00) | ||
IL-6 (ng/L) | 22.01 (11.90, 42.87) | ||
Serum creatinine (mg/dl) | 6.17 (4.69, 9.88) | ||
Blood urea nitrogen (mg/dl) | 68.38 ± 31.13 | ||